IASEVOLI, FELICE
 Distribuzione geografica
Continente #
NA - Nord America 1.969
EU - Europa 1.030
AS - Asia 770
AF - Africa 62
SA - Sud America 14
OC - Oceania 1
Totale 3.846
Nazione #
US - Stati Uniti d'America 1.933
IT - Italia 523
SG - Singapore 358
CN - Cina 305
IE - Irlanda 102
VN - Vietnam 89
SE - Svezia 82
FI - Finlandia 75
NL - Olanda 70
CI - Costa d'Avorio 60
UA - Ucraina 58
DE - Germania 42
CA - Canada 36
GB - Regno Unito 31
FR - Francia 10
IS - Islanda 10
BR - Brasile 9
HU - Ungheria 7
IN - India 5
RU - Federazione Russa 5
CL - Cile 4
ES - Italia 4
PK - Pakistan 4
ID - Indonesia 3
IR - Iran 3
BG - Bulgaria 2
NG - Nigeria 2
PL - Polonia 2
RO - Romania 2
TR - Turchia 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
CH - Svizzera 1
GR - Grecia 1
SI - Slovenia 1
TW - Taiwan 1
Totale 3.846
Città #
Chandler 354
Singapore 293
Millbury 146
Princeton 103
Dong Ket 89
Nanjing 87
Naples 78
Wilmington 76
Santa Clara 75
Beijing 74
Des Moines 70
Jacksonville 66
Ashburn 65
Amsterdam 63
Napoli 63
Boston 43
Norwalk 43
Nanchang 32
Ottawa 30
Rome 30
Shenyang 27
Seattle 24
Houston 23
Jiaxing 19
Hebei 17
Lawrence 17
Changsha 14
Woodbridge 14
Milan 12
Boardman 11
Falls Church 11
Dublin 10
Reykjavík 10
Tianjin 9
Atlanta 7
Ortona 7
Redwood City 6
Brooklyn 5
Concordia Sagittaria 5
Gallipoli 5
Genova 5
Kronberg 5
Portici 5
Salerno 5
Caivano 4
Council Bluffs 4
Fairfield 4
Fremont 4
Kunming 4
New York 4
Tamworth 4
Ann Arbor 3
Avellino 3
Bari 3
Dearborn 3
Florence 3
Foligno 3
Lappeenranta 3
Monza 3
Pescara 3
Rawalpindi 3
Richmond 3
Serra 3
Shanghai 3
Somma Vesuviana 3
Southend 3
Zhuhai 3
Abuja 2
Angri 2
Arzano 2
Aversa 2
Barakaldo 2
Brasília 2
Bucharest 2
Cambridge 2
Cankaya 2
Cerro Maggiore 2
Dalmine 2
Eindhoven 2
Fisciano 2
Formia 2
Genoa 2
Hangzhou 2
Hanover 2
Liscate 2
Martock 2
Miller Place 2
Molfetta 2
Niterói 2
Nola 2
Orlando 2
Perugia 2
Pune 2
Rowley 2
San Vito al Tagliamento 2
Santa Marinella 2
Santiago 2
Sarno 2
Selargius 2
Sennori 2
Totale 2.295
Nome #
Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia 69
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 65
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 62
Obsessive-Compulsive Aspects and Pathological Gambling in an Italian Sample 60
Neuropsychiatric disorders in Cushing's syndrome. 60
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 59
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 58
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 57
The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment 56
Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis. 54
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 52
The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment 47
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 47
Alexithymia, suicidal ideation, and serum lipid levels among drug-na?ve outpatients with obsessive-compulsive disorder 46
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables 46
Efficacia e sicurezza dell’asenapina in pazienti con episodi maniacali e misti associati a disturbo bipolare I 46
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 45
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 44
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients 44
The Relationships between Cholesterol and Suicide: An Update 43
The relationship between emotional regulation and eating behaviour: a multidimensional analysis of obesity psychopathology 43
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression 41
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 41
Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder 40
May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview. 40
Psychopathological Dimensions in Eating Disorders (E. D.) 39
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 39
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients 39
Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders 38
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. 38
The role of melatonin in mood disorders 38
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs 38
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 37
Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. 37
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 37
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 37
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice 36
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 36
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice 36
C-reactive protein level and its relationship with suicide risk and alexithymia among newly diagnosed, drug-naïve patients with non-affective psychosis 35
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 35
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 35
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 35
The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. 34
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 34
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 34
M170. GENETIC CHARACTERIZATION OF A COHORT OF PATIENTS AFFECTED BY SCHIZOPHRENIA. THE ROLE FOR RARE STRUCTURAL VARIANTS IN MODULATING TREATMENT RESISTANT ENDOPHENOTYPES: PRELIMINARY DATA 34
Efficacy and Clinical Determinants of Antipsychotic Polypharmacy in Psychotic Patients Experiencing an Acute Relapse and Admitted to Hospital Stay: Results from a Cross-Sectional and a Subsequent Longitudinal Pilot Study 33
Fisiopatologia cellulare e molecolare 33
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 33
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 33
Cariprazine (RGH-188): A new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 33
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 32
Alexithymia and Breast Cancer Surgery: A Systematic Review 32
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 31
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 31
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials 31
Alexithymia, Suicide Ideation, C-Reactive Protein, and Serum Lipid Levels Among Outpatients with Generalized Anxiety Disorder 31
Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole 30
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews 30
Can the "connectomic way" provide a link between molecular neurobiology and phenomenological psychopathology? the case of schizophrenia 30
Aripiprazole for relapse prevention and craving in alcohol use disorder: Current evidence and future perspectives 29
Aderenza al trattamento in pazienti bipolari tipo-II in fase acuta depressiva: correlati psicopatologici del temperamento ciclotimico e “therapeutic sensation seeking” in risposta alla incapacità di sopportazione del dolore soggettivo 29
Cotard’s Syndrome: Clinical Case Presentation and Literature Review 29
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 28
Cotard's Syndrome after breast surgery successfully treated with aripiprazole augmentation of escitalopram: a case report 28
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia 28
Cerebellar transcranial direct current stimulation in children with autism spectrum disorder: A pilot study on efficacy, feasibility, safety, and unexpected outcomes in tic disorder and epilepsy 28
Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins 27
Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases 27
Efficacy and safety of long acting injectable atypical antipsychotics: a review 26
Increased Signaling via Adenosine A1Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a 26
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders 26
Does the "Silver Bullet" Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients 26
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: An exploratory study 26
Alexithymia and its relationships with acute phase proteins and cytokine release: an updated review 26
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 26
Ketamine-related expression of glutamatergic postsynaptic density genes: possible implications in psychosis 25
S-Adenosyl-L-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study. 25
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder 25
XVIIIesimo congresso nazionale SOPSI (“Società Italiana di Psicopatologia), Torino 12-15 febbraio 2014, – Simposio dal titolo:” Hic sunt leones: clinica ed evoluzione nelle età della vita della resistenza al trattamento farmacologico in psichiatria.” Moderatori Prof. G. Muscettola e Prof. A. de Bartolomeis. Relazione dal titolo:” La farmacoresistenza nella Depressione Maggiore e nella acuzie depressiva del Bipolare: focus sugli stati misti sotto-soglia ed evoluzione nelle età della vita.”. Co-relatori: Prof. F. Iasevoli, Prof. G. Martinotti, Prof. D. De Berardis. 25
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses 25
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 24
Striatal expression of Homer1a is affected by genotype but not dystonic phenotype of tottering mice: a model of spontaneously occurring motor disturbances 24
The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted 24
Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study 23
Depression and Anxiety Symptoms "Among the Waves" of the COVID-19 Pandemic in Obsessive Compulsive Disorder and Adjustment Disorder Patients 23
Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action 23
Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions 23
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review 23
Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression 23
The expression of genes involved in glucose metabolism is affected by N-methyl-D-aspartate receptor antagonism: a putative link between metabolism and an animal model of psychosis 22
Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis 22
Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins 22
An update of safety of clinically used atypical antipsychotics 22
Creativity and psychiatric illness: A functional perspective beyond chaos 22
Erratum: Treatment adherence towards prescribed medications in bipolar-II acute depressed patients: Relationship with cyclothymic temperament and "therapeutic sensation seeking" in response towards subjective intolerance to pain" (Journal of Affective Disorders (2013) 151:2 (596-604) DOI:10.1016/j.jad.2013.07.004) 22
Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases 22
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia 22
Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases 21
Totale 3.476
Categoria #
all - tutte 19.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020179 0 0 14 8 21 5 13 2 0 48 43 25
2020/2021372 24 16 32 15 18 56 26 10 45 18 19 93
2021/2022719 22 1 5 15 9 53 12 30 116 71 102 283
2022/2023891 129 70 26 56 113 132 5 88 130 71 57 14
2023/2024612 30 126 54 50 29 28 27 81 20 19 95 53
2024/2025453 194 252 7 0 0 0 0 0 0 0 0 0
Totale 4.141